AF
LAB icon

Allworth Financial’s Standard BioTools LAB Stock Holding History

Allworth Financial’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47K Buy
4,219
+2,738
+185% +$2.59K ﹤0.01% 4298
2026
Q1 		$1.36K Buy
1,481
+790
+114% +$956 ﹤0.01% 4475
2025
Q4 		$885 Sell
691
-113
-14% -$152 ﹤0.01% 4394
2025
Q3 		$1.05K Buy
804
+26
+3% +$34 ﹤0.01% 4236
2025
Q2 		$934 Sell
778
-36
-4% -$40 ﹤0.01% 3978
2025
Q1 		$1K Buy
814
+114
+16% +$160 ﹤0.01% 3467
2024
Q4 		$1.28K Sell
700
-252
-26% -$469 ﹤0.01% 3319
2024
Q3 		$1.84K Buy
952
+107
+13% +$210 ﹤0.01% 3001
2024
Q2 		$1.85K Hold
845
– – ﹤0.01% 2957
2024
Q1 		$2.29K Hold
845
– – ﹤0.01% 2757
2023
Q4 		$1.87K Hold
845
– – ﹤0.01% 2704
2023
Q3 		$2.45K Buy
845
+145
+21% +$379 ﹤0.01% 2446
2023
Q2 		$1.35K Hold
700
– – ﹤0.01% 2640
2023
Q1 		$1.36K Buy
+700
New +$1.38K ﹤0.01% 2555

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Allworth Financial's LAB Position: Q2 2026 in Review

Allworth Financial increased its Standard BioTools (LAB) stake by 185% in Q2 2026, buying an estimated $2.59K and bringing the position to 4,219 shares worth $3.47K. The position accounts for ﹤0.01% of the portfolio, ranked #4298.

Allworth Financial first reported a position in LAB in Q1 2023 and has held it in 14 quarters since. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Allworth Financial held 4,219 shares of Standard BioTools worth $3.47K as of Q2 2026.
  • Allworth Financial bought 2,738 Standard BioTools shares in Q2 2026, an estimated $2.59K.
  • Standard BioTools made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4298 holding.
  • Allworth Financial first reported a position in Standard BioTools in Q1 2023 and has held it in 14 quarters since.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.